CD155 surface expression was measured on several solid tumor cell lines, including A549 (NSCLC), Capan-1 (pancreatic cancer), HepG2 ( liver cancer), U251 (brain cancer), MDA-MB-231 (breast cancer), and HT29 (colon cancer). Here, PVR is linked to breast carcinoma.